These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 20066739)

  • 21. Susceptibility of inhibitors against 3C protease of coxsackievirus A16 and enterovirus A71 causing hand, foot and mouth disease: A molecular dynamics study.
    Jetsadawisut W; Nutho B; Meeprasert A; Rungrotmongkol T; Kungwan N; Wolschann P; Hannongbua S
    Biophys Chem; 2016 Dec; 219():9-16. PubMed ID: 27668727
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biochemical characterization of recombinant Enterovirus 71 3C protease with fluorogenic model peptide substrates and development of a biochemical assay.
    Shang L; Zhang S; Yang X; Sun J; Li L; Cui Z; He Q; Guo Y; Sun Y; Yin Z
    Antimicrob Agents Chemother; 2015 Apr; 59(4):1827-36. PubMed ID: 25421478
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The combination of pleconaril, rupintrivir, and remdesivir efficiently inhibits enterovirus infections in vitro, delaying the development of drug-resistant virus variants.
    Ianevski A; Frøysa IT; Lysvand H; Calitz C; Smura T; Schjelderup Nilsen HJ; Høyer E; Afset JE; Sridhar A; Wolthers KC; Zusinaite E; Tenson T; Kurg R; Oksenych V; Galabov AS; Stoyanova A; Bjørås M; Kainov DE
    Antiviral Res; 2024 Apr; 224():105842. PubMed ID: 38417531
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Novel Enterovirus 71 (EV71) Virulence Determinant: The 69th Residue of 3C Protease Modulates Pathogenicity.
    Li B; Yue Y; Zhang Y; Yuan Z; Li P; Song N; Lin W; Liu Y; Gu L; Meng H
    Front Cell Infect Microbiol; 2017; 7():26. PubMed ID: 28217559
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antiviral activities of peptide-based covalent inhibitors of the Enterovirus 71 3C protease.
    Tan YW; Ang MJ; Lau QY; Poulsen A; Ng FM; Then SW; Peng J; Hill J; Hong WJ; Chia CS; Chu JJ
    Sci Rep; 2016 Sep; 6():33663. PubMed ID: 27645381
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The enterovirus 3C protease inhibitor SG85 efficiently blocks rhinovirus replication and is not cross-resistant with rupintrivir.
    Lacroix C; George S; Leyssen P; Hilgenfeld R; Neyts J
    Antimicrob Agents Chemother; 2015 Sep; 59(9):5814-8. PubMed ID: 26055377
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Selection and Characterization of Rupintrivir-Resistant Norwalk Virus Replicon Cells
    Kitano M; Hosmillo M; Emmott E; Lu J; Goodfellow I
    Antimicrob Agents Chemother; 2018 May; 62(5):. PubMed ID: 29530860
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Real-time monitoring of human enterovirus (HEV)-infected cells and anti-HEV 3C protease potency by fluorescence resonance energy transfer.
    Tsai MT; Cheng YH; Liu YN; Liao NC; Lu WW; Kung SH
    Antimicrob Agents Chemother; 2009 Feb; 53(2):748-55. PubMed ID: 19015331
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optimize the interactions at S4 with efficient inhibitors targeting 3C proteinase from enterovirus 71.
    Zhang L; Huang G; Cai Q; Zhao C; Tang L; Ren H; Li P; Li N; Huang J; Chen X; Guan Y; You H; Chen S; Li J; Lin T
    J Mol Recognit; 2016 Nov; 29(11):520-527. PubMed ID: 27185390
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design, synthesis, and evaluation of 3C protease inhibitors as anti-enterovirus 71 agents.
    Kuo CJ; Shie JJ; Fang JM; Yen GR; Hsu JT; Liu HG; Tseng SN; Chang SC; Lee CY; Shih SR; Liang PH
    Bioorg Med Chem; 2008 Aug; 16(15):7388-98. PubMed ID: 18583140
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and structure-activity relationship of α-keto amides as enterovirus 71 3C protease inhibitors.
    Zeng D; Ma Y; Zhang R; Nie Q; Cui Z; Wang Y; Shang L; Yin Z
    Bioorg Med Chem Lett; 2016 Apr; 26(7):1762-6. PubMed ID: 26916437
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fragment-wise design of inhibitors to 3C proteinase from enterovirus 71.
    Wu C; Zhang L; Li P; Cai Q; Peng X; Yin K; Chen X; Ren H; Zhong S; Weng Y; Guan Y; Chen S; Wu J; Li J; Lin T
    Biochim Biophys Acta; 2016 Jun; 1860(6):1299-307. PubMed ID: 26987809
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structure-assisted design of mechanism-based irreversible inhibitors of human rhinovirus 3C protease with potent antiviral activity against multiple rhinovirus serotypes.
    Matthews DA; Dragovich PS; Webber SE; Fuhrman SA; Patick AK; Zalman LS; Hendrickson TF; Love RA; Prins TJ; Marakovits JT; Zhou R; Tikhe J; Ford CE; Meador JW; Ferre RA; Brown EL; Binford SL; Brothers MA; DeLisle DM; Worland ST
    Proc Natl Acad Sci U S A; 1999 Sep; 96(20):11000-7. PubMed ID: 10500114
    [TBL] [Abstract][Full Text] [Related]  

  • 34. EV71 3C protease cleaves host anti-viral factor OAS3 and enhances virus replication.
    Zhou X; Tian L; Wang J; Zheng B; Zhang W
    Virol Sin; 2022 Jun; 37(3):418-426. PubMed ID: 35504537
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In Vitro Assessment of Combinations of Enterovirus Inhibitors against Enterovirus 71.
    Wang Y; Li G; Yuan S; Gao Q; Lan K; Altmeyer R; Zou G
    Antimicrob Agents Chemother; 2016 Sep; 60(9):5357-67. PubMed ID: 27353263
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 3C protease of enterovirus 68: structure-based design of Michael acceptor inhibitors and their broad-spectrum antiviral effects against picornaviruses.
    Tan J; George S; Kusov Y; Perbandt M; Anemüller S; Mesters JR; Norder H; Coutard B; Lacroix C; Leyssen P; Neyts J; Hilgenfeld R
    J Virol; 2013 Apr; 87(8):4339-51. PubMed ID: 23388726
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro antiviral activity of AG7088, a potent inhibitor of human rhinovirus 3C protease.
    Patick AK; Binford SL; Brothers MA; Jackson RL; Ford CE; Diem MD; Maldonado F; Dragovich PS; Zhou R; Prins TJ; Fuhrman SA; Meador JW; Zalman LS; Matthews DA; Worland ST
    Antimicrob Agents Chemother; 1999 Oct; 43(10):2444-50. PubMed ID: 10508022
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of EV71 3C polymorphisms with clinical severity.
    Ma HY; Lu CY; Tsao KC; Shih HM; Cheng AL; Huang LM; Chang LY
    J Microbiol Immunol Infect; 2018 Oct; 51(5):608-613. PubMed ID: 28711442
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of a luciferase-based biosensor to assess enterovirus 71 3C protease activity in living cells.
    Zhang Y; Ke X; Zheng C; Liu Y; Xie L; Zheng Z; Wang H
    Sci Rep; 2017 Sep; 7(1):10385. PubMed ID: 28871120
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Function and Mechanism of Enterovirus 71 (EV71) 3C Protease.
    Wen W; Qi Z; Wang J
    Curr Microbiol; 2020 Sep; 77(9):1968-1975. PubMed ID: 32556480
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.